🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Effect of Immersive Virtual Reality With Multisensory Stimulation on the Functional Impact of Hemineglect Secondary to a Right-Sided Stroke

RecruitingNAAges 18 Years - anyAllHopital La Musse
NCT06719063 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

A stroke is a common and potentially serious condition that affects 130,000 people each year in France. It is the second leading cause of major cognitive disorders after Alzheimer's disease. Hemineglect is a frequently observed cognitive impairment following a stroke. The individual becomes unable to orient themselves or respond to stimuli appearing in the contralesional hemispace. Hemineglect occurs in approximately 25-30% of stroke patients, with the right hemisphere being affected in 90% of cases. Despite potential spontaneous recovery within the first 2 to 3 months post-stroke, neglect tends to persist chronically. One-third of patients suffer from long-term neglect. The condition is more severe after a right-sided lesion. The functional impact is significant, particularly when considering the anosognosia and anosodiaphoria often associated with it. Rehabilitation stays are longer

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patient aged over 18 years * Diagnosis of first ischemic right stroke established by a neurologist using clinical examination and brain imaging (CT scan or MRI) * Stroke occurring less than 3 months ago * Presence of left hemineglect, diagnosed using the Neglect Assessment Battery (NAB) * Normal vision or corrected to normal * Patient affiliated with the social security system Exclusion Criteria: * History of neurological or psychiatric illness * Epilepsy * Craniotomy * Limited range of cervical motion due to orthopedic disorders * Moderate or severe deafness (hearing loss of 40 dB in one ear, as measured by tonal audiometry) * Anosmia (loss of smell) * Asthmatic disease * Pregnant women or women suspected of being pregnant * Breastfeeding women * Severe neurocognitive disorders with an MMSE score \< 21 * Patient under legal protection measures * Minor patient * Patient enrolled in another research protocol
💊

What it tests

  • Multisensory Virtual Reality
📍

Where

1 site
Hôpital La Musse
Saint-Sébastien-de-Morsent, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy